Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Von Schütz

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|May 8, 2001
Quantification of angiogenesis stimulators in children with solid malignanciesH Pavlakovic, V Von Schütz, J Rössler, et al.
British Journal of Haematology|May 1, 2001
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemiaJ P Vieira Pinheiro, H J Müller, D Schwabe, et al.
British Journal of Haematology|September 6, 2000
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocolsH J Müller, L Löning, A Horn, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|May 8, 2001
Quantification of angiogenesis stimulators in children with solid malignanciesH Pavlakovic, V Von Schütz, J Rössler, et al.
British Journal of Haematology|May 1, 2001
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemiaJ P Vieira Pinheiro, H J Müller, D Schwabe, et al.
British Journal of Haematology|September 6, 2000
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocolsH J Müller, L Löning, A Horn, et al.
Pageof 1